The development of treatment strategies to circumvent this problem may offer attractive opportunities for pharmaceutical intervention in the pathogenesis of obesity, which is the subject of our other study using MTS-leptin—a modified leptin with improved permeation across the BBB. The gene discussed is LEP; the disease is obesity disorder.